Cargando…
Histopathological Grading, Clinical Staging and CD 31 Expression of Canine Splenic Hemangiosarcoma
SIMPLE SUMMARY: Canine hemangiosarcoma is an aggressive cancer with a short median survival time, commonly found in the spleen of older dogs. There are limited tests available to provide clinically useful prognostic information to guide therapies once a diagnosis is made. Predictors of survivability...
Autores principales: | Chu, Ka-To, Nekouei, Omid, Sandy, Jeanine Rhoda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054225/ https://www.ncbi.nlm.nih.gov/pubmed/36977229 http://dx.doi.org/10.3390/vetsci10030190 |
Ejemplares similares
-
A canine case of splenic hemangiosarcoma complicated with infectious splenic abscess
por: Oyamada, Tomohiro, et al.
Publicado: (2022) -
Hyperferritinemia in Dogs with Splenic Hemangiosarcoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013) -
Cellular atypia is negatively correlated with immunohistochemical reactivity
of CD31 and vWF expression levels in canine hemangiosarcoma
por: MAHARANI, Aprilia, et al.
Publicado: (2018) -
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma
por: Gardner, Heather L., et al.
Publicado: (2015) -
Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma
por: Bray, Jonathan P., et al.
Publicado: (2020)